Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Earnings per Share (EPS) (Basic) of $-1.44 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-17.66M |
|
-- |
|
-- |
|
$19.15M |
|
$-19.15M |
|
$1.49M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-19.15M |
|
$-19.52M |
|
12.24M |
|
12.24M |
|
|
Earnings per Share (EPS) (Basic) |
$-1.44 |
$-1.44 |
|
| Balance Sheet Financials | |
$122.83M |
|
$0.25M |
|
$2.26M |
|
$125.08M |
|
$13.33M |
|
-- |
|
$0.76M |
|
$14.09M |
|
$110.99M |
|
$110.99M |
|
$110.99M |
|
12.25M |
|
| Cash Flow Statement Financials | |
$-33.02M |
|
$35.87M |
|
-- |
|
$17.87M |
|
$20.71M |
|
$2.85M |
|
$3.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.91% |
|
-15.91% |
|
-14.12% |
|
-15.91% |
|
$9.06 |
|
$-2.70 |
|
$-2.70 |
|